RXi Pharmaceuticals Announces Upcoming Presentations
RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced upcoming presentations at AsiaTIDES and at the ROTH 25th Annual Conference.